European Pharmaceutical InnovationNovo Nordisk Licenses Parkinson's Therapy to AI Startup, Shares Rise 24.9% in 30 DaysSalvado•Jun 5, 2026
European Pharmaceutical InnovationNovo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI Partner as Stock Surges 25%Salvado•May 18, 2026